Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 7
Original Research
Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,964 | Dovepress* | 11,743+ | 2,374 | 14,117 | |
| PubMed Central* | 2,221 | 571 | 2,792 | ||
| Totals | 13,964 | 2,945 | 16,909 | ||
|
*Since 9 August 2011 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed and Google Scholar